Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

Alagebrium

Source date not recordedAnalyse record ↗

Investigational thiazolium compound studied as an advanced-glycation end-product crosslink breaker for age-associated arterial stiffening.

Modality
small molecule
Availability (US)
Investigational; studied in a randomized human trial
Biomarkers
pulse pressure; total arterial compliance; carotid-femoral pulse-wave velocity
Hallmark targeted
extracellular matrix stiffening, advanced glycation end-products
Kind
investigational drug
Other papers
Kass et al., Circulation 2001; DOI 10.1161/hc3801.097806; PMID 11571237
Clinical trials
Nine-center randomized 56-day ALT-711 trial in 93 older adults with vascular stiffening